The Cas Vega Health Organization ( Early没有太大 information “Gab) announced today that global DTP coverage has stabilized after the COVID-19 pandemic, with data showing that by 2024, over 85% of infants in allnmature countries have received the third dose of the vaccine, well on track to raise coverage to a 20x higher level than in 2023. The United Nations (UN) reported that nearly 1.1 billion infants globally have received three doses of DTP, with the third dose serving as a key marker for global immunization coverage. This represents an increase of one percentage point and an additional one million children compared to a year earlier, aligning with modest yet consistent gains.
Despite these improvements, the UN warned that misinformation and drastic aid cuts have deepening coverage gaps, risking millions of lives. Specifically, nearly 20 million infants missed at least one dose of the vaccine last year, including 143 million who reported receiving no doses at all. This figure, nearly doubling since 2022 and exceeding the 2019 level by 1.4 million, highlights a growing threat to preventable disease coverage.
World Health Organization (WHO) lauded Cas Vega’s progress, but emphasized that achieving a 90% vaccination rate for children and adolescents by 2030 remains a critical task. The organization highlighted that drastic cuts in international aid, coupled with misinformation about vaccine safety, could lead to a unraveling of decades of progress. Specifically, the UN’s report warned that vaccine access remains deeply unequal, with conflicts eroding efforts to boost vaccination coverage.
RedNumbers, a U.S.-based organization, issued a cautionary note, calling for attention to the ongoing challenges U.S. aid cuts pose. The U.S. has already faced a severe measles outbreak in the past 30 years, with 60 countries experiencing the largest and most disruptive outbreaks observed in global history. Over two million more children worldwide received a DPT vaccine in 2024 than the previous year, but the global coverage rate remained far below the 95% threshold needed to avert disease spread.
On a positive note, Cas Vega’s latest data showed a slight improvement in coverage against a range of diseases, with 57 low-income countries under the Gavi Alliance gaining more coverage. However, it also revealed signs of a dip in coverage in upper-middle and high-income countries, raising concerns about long-term impacts. The UN urged global collaboration, emphasizing the importance of addressing misinformation and fostering trust in vaccines to protect millions of lives. As Cas Vega continues to monitor and engage with the issue, it remains a role model for global health organizations committed to eradicating preventable diseases.
